India and China Rise: Pet Boom and Livestock Needs Lift the Veterinary Rapid Test Market
Veterinary medicine is moving toward earlier answers. A result in minutes rather than days can change a treatment plan, limit an outbreak on a farm, or reassure a pet owner during a routine visit. That need for speed is why veterinary rapid tests are among the fastest-growing segments of animal diagnostics.
This post summarizes the market size, growth drivers, major players, and regional outlook, based on Grand View Research's Veterinary Rapid Test Market report.
Market Size & Forecast
The global veterinary rapid test market was valued at USD 820.8 million in 2023. It is estimated at USD 1,157.0 million in 2026 and projected to reach USD 1,847.6 million by 2030, a CAGR of 12.3% from 2024 to 2030.
Some segment highlights from 2023:
- Test kits led the product segment with about 80.2% of revenue (USD 658.6 million), and the report names them the fastest-growing product category.
- Immunoassays, including ELISA and lateral flow formats, led the technology segment.
- Virology was the largest testing category, at about 33% share.
- Companion animals accounted for roughly 55.8% of revenue, with dogs the largest sub-segment.
- Veterinary hospitals and clinics were the dominant end users, at about 68.7%.
Go Deeper! Ask Prism AI about the Global Veterinary Rapid Test Market. Get instant answers to questions about market sizing, growth drivers and their impact, and more. Try Prism AI
Growth Drivers & Recent Trends
What is fueling demand
- Growing pet ownership and spending. The humanization of pets has made owners more willing to pay for screening and preventive care.
- A shift to preventive healthcare. Clinics increasingly build routine rapid tests into wellness programs. IDEXX's SNAP 4Dx Plus, recommended annually for Lyme disease, heartworm, ehrlichiosis, and anaplasmosis, is a well-known example.
- Pet insurance adoption. In the U.S., policies commonly cover diagnostic testing, which encourages owners to authorize it.
- Technology advances. Better immunoassays, PCR-based rapid methods, and digital result interpretation are improving sensitivity and specificity. In 2022, researchers at La Trobe University developed a rapid isothermal PCR test that detects liver fluke in about an hour.
- Livestock health and biosecurity. Government programs and on-farm testing support demand. The USDA's APHIS, for instance, has purchased diagnostic kits to test livestock for African Swine Fever and Foot and Mouth Disease.
Trends worth watching
- AI-enabled diagnostics. Zoetis expanded its Vetscan Imagyst system in 2023 with AI applications for dermatology and equine fecal egg counts.
- At-home and on-farm testing. Easy-to-use kits for conditions such as heartworm and feline leukemia are extending diagnostics beyond the clinic.
- Consolidation and portfolio expansion. Mars completed its acquisition of Heska in 2023, and Heska had earlier acquired LightDeck Diagnostics to build out its immunoassay capabilities.
- Steady launches. Recent examples include Zoetis's Vetscan Mastigram+ for on-farm mastitis detection, IDEXX's SNAP Leish 4Dx Test for vector-borne disease screening, and new kits from Gold Standard Diagnostics and BioStone Animal Health.
The main challenge
Accuracy remains the biggest restraint. Some rapid tests have limited sensitivity or specificity, which risks false negatives or false positives. The report cites a comparison of commercial ELISA kits for canine parvovirus against lab-based qPCR, in which the rapid kits showed sensitivity of roughly 45%. Manufacturers that improve test performance and build clinician confidence are likely to benefit most.
Major Market Players
The market combines large diagnostics and animal health companies with specialized and emerging players. Key companies profiled in the report include:
- Zoetis
- IDEXX Laboratories, Inc.
- Virbac
- Heska Corporation (Mars Inc.)
- Thermo Fisher Scientific Inc.
- Neogen Corporation
- Prometheus Bio Inc.
- Fassisi GmbH
- Biopanda Reagents Ltd
- Boster Biological Technology
Their strategies center on new product launches, partnerships, acquisitions, and regional expansion. Regulatory requirements favor companies that can invest in R&D and compliance, which can make market entry harder for smaller firms.
Want the full numbers behind these estimates? Download a free sample of the Veterinary Rapid Test Market report to see segment-level forecasts, trend analysis, and the report structure.
Geographic Focus
North America was the largest regional market in 2023, with a 36.6% revenue share. Extensive pet insurance coverage in the U.S. supports routine diagnostic testing, and in Canada, reportable livestock diseases such as avian influenza, bovine tuberculosis, and chronic wasting disease sustain demand for fast, reliable testing.
Europe held the second-largest share. Point-of-care and molecular diagnostics are driving adoption, and pet insurance and zoonotic disease concerns add to demand. Germany shows steady demand tied to the high prevalence of urinary tract infections in companion animals, while the UK and France are also highlighted as markets with strong growth prospects.
Asia Pacific is expected to grow at the fastest regional CAGR. The drivers vary by country:
- India: government support for diagnostic availability, plus a growing livestock population.
- China: rising middle-class incomes and fast-growing urban pet ownership.
- South Korea: a strong focus on broiler farms and viral disease control.
- Australia: a large cattle industry.
Latin America and the Middle East & Africa are smaller but have clear drivers. In Brazil, disease-related losses in beef cattle underscore the value of diagnostics. In Saudi Arabia, the push to expand poultry production under Vision 2030 is increasing the need for on-farm testing.
The Bottom Line
The veterinary rapid test market is on track to grow from about USD 0.8 billion in 2023 to nearly USD 1.85 billion by 2030. More pets, more preventive care, better technology, and the need for fast livestock disease control are all pushing in the same direction. Companies that combine accuracy, convenience, and digital integration are best placed to lead.
Mapping the U.S. healthcare landscape? Explore the U.S. Healthcare Facility Mapping & Intelligence Platform for facility-level data and insights.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Jocuri
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Alte
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness